Form 8-K - Current report:
SEC Accession No. 0001193125-09-197301
Filing Date
2009-09-24
Accepted
2009-09-24 16:50:56
Documents
2
Period of Report
2009-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17538
2 LEASE TERMINATION AND WARRANT PURCHASE AGREEMENT dex101.htm EX-10.1 71920
  Complete submission text file 0001193125-09-197301.txt   91319
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 091085385
SIC: 2835 In Vitro & In Vivo Diagnostic Substances